ProCE Banner Activity

IFM 2013-04: VTD vs VCD Before ASCT in Patients With MM

Slideset Download
Conference Coverage
VTD showed superior rates of ≥ VGPR vs VCD as induction therapy. Treatment with VCD resulted in higher rates of hematologic toxicity, whereas VTD resulted in more peripheral neuropathy.

Released: December 09, 2015

Expiration: December 07, 2016

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Millennium Takeda

Seagen